ViiV, Janssen’s two-drug HIV regimen hits PhIII targets
ViiV Healthcare and Janssen have unveiled positive headline data from a late-stage trial of their injectable two-drug regimen for the treatment of HIV.
Read More
Tag: atlas
Atlas awarded £2m grant for infectious disease test
Atlas Genetics has been awarded a £2 million grant by Innovate UK for a project that aims to support the adoption of its io rapid diagnostic platform into UK sexual health clinics.
Read More
Dementia atlas shows care inequalities across England
Huge differences in the quality of care of patients with dementia have been revealed by the government’s new Dementia Atlas.
Read More
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
